Morepen Laboratories Limited
Morepen Laboratories Limited (MOREPENLAB.BO) Stock Overview
Explore Morepen Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
24.2B
P/E Ratio
24.44
EPS (TTM)
$1.79
ROE
0.09%
MOREPENLAB.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Morepen Laboratories Limited (MOREPENLAB.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 62.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $61.06.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.44 and a market capitalization of 24.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.